Sector ratings Iqvia Holdings Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 20:05:07 19/09/2024 BST			5-day change	1st Jan Change
245.10 ^USD	+1.00%		+2.78%	+5.90%

09-06	Veeva Systems: leader in cloud solutions for the life sciences industry
09-04	'Brighter Skies' Ahead for IQVIA As EPS Set to 'Reaccelerate', RBC Capital Says	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	ESG Refinitiv	Capi. ($)
IQVIA HOLDINGS INC.		B	43.75B
LONZA GROUP AG		A	45.62B
ALNYLAM PHARMACEUTICALS, INC.	-	B	35.24B
CELLTRION, INC.		C	30.45B
MODERNA, INC.	-	B-	27.67B
ICON PUBLIC LIMITED COMPANY		B-	24.23B
UNITED THERAPEUTICS CORPORATION		B+	15.35B
BIO-TECHNE CORPORATION		B+	11.94B
MEDPACE HOLDINGS, INC.		C+	10.97B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		C+	10.65B
QIAGEN N.V.		A	10.15B
REVOLUTION MEDICINES, INC.	-	C-	7.31B
IONIS PHARMACEUTICALS, INC.	-	B+	6.54B
BACHEM HOLDING AG		B-	6.54B
HANGZHOU TIGERMED CONSULTING CO., LTD		B+	5.61B
BLUEPRINT MEDICINES CORPORATION		B-	5.48B
PHARMARON BEIJING CO., LTD.		B+	4.68B
ALKERMES PLC		B	4.57B
Average		B	17.04B
Weighted average by Cap.		B